Top compounds associated with response to LGALS8


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.14 0.0002
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.14 0.0002
mRNA PD-0332991 GDSC1000 pan-cancer AAC 0.14 0.0002
mRNA CD-437 CTRPv2 pan-cancer AAC 0.12 0.0003
mRNA Nutlin-3 CTRPv2 pan-cancer AAC 0.12 0.0003
mRNA Compound 23 citrate CTRPv2 pan-cancer AAC 0.12 0.0003
mRNA Bleomycin GDSC1000 pan-cancer AAC 0.14 0.0003
mRNA KIN001-270 GDSC1000 pan-cancer AAC -0.13 0.0003
mRNA 17-AAG CCLE pan-cancer AAC 0.18 0.0003
mRNA lapatinib CCLE pan-cancer AAC 0.17 0.0004
Download CSV